Radhika Jagannathan
Columbia University Irving Medical Center(US)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Alzheimer's disease research and treatments, Cellular transport and secretion, Dementia and Cognitive Impairment Research, Autism Spectrum Disorder Research
Most-Cited Works
- → Lamellipodin, an Ena/VASP Ligand, Is Implicated in the Regulation of Lamellipodial Dynamics(2004)335 cited
- → Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling Pathway(2010)260 cited
- → AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol(2016)59 cited
- → CREB3L2-ATF4 heterodimerization defines a transcriptional hub of Alzheimer’s disease gene expression linked to neuropathology(2023)24 cited
- → Clinical Use of Lecanemab at an Academic Medical Center(2024)2 cited
- → Negative Regulation of the Hippo Pathway by the Ajuba LIM Proteins(2014)
- → Clinical evidence and biological considerations in the clinical use of lecanemab – experience at an academic medical center(2025)
- → Work-up and Counseling for First Evaluation of Cognitive Decline: A Simulation-based Educational Tool and Embedded Learning Results (P8-7.001)(2024)
- Lamellipodin, a novel Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics(2004)
- → Transcriptional deregulation in Parkinson’s disease by ATF4 transcription factor heterodimers (2891)(2021)